EU, UK drug regulators rally behind AstraZeneca vaccine after safety concerns By Reuters
By Anthony Deutsch, Toby Sterling and Alistair Smout AMSTERDAM/LONDON (Reuters) - Drug watchdogs in the EU and Britain moved to shore up confidence in AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine on Thursday after reports of blood clots prompted more than a dozen nations to suspend inoculations. The safety scare is the latest challenge for AstraZeneca and its ambition to produce a "vaccine for the...
Continue reading